GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist

计划入组 80 人 · 首次发布于 2020 年 1 月 23 日

A Single Arm, Phase Ib/II Trial of Single Agent Pacritinib in Patients With 1q21.3 Amplified Solid Tumors Enriching for Interleukin-1 Receptor-associated Kinase 1 Pathway Activation (PAIR)

计划入组 74 人 · 首次发布于 2020 年 8 月 20 日

Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.

计划入组 16 人 · 首次发布于 2020 年 3 月 27 日

interleukin-1 receptor antagonists (Neoloch)

Interleukin-1 receptor(Amgen, Inc.)

1-naphthaleneacetic acid

C₁₂H₁₀O₂

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

FDA Grants Orphan Drug Designation to Kiniksa's KPL-387 for Pericarditis Treatment

Kiniksa Reports Strong ARCALYST Growth, Advances KPL-387 for Recurrent Pericarditis Development

Kiniksa Pharmaceuticals Advances KPL-387 Phase 2/3 Trial for Recurrent Pericarditis